Datamonitor: Commercial Insight - Antihormonal Cancer Therapies on reports-research.com

Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the antihormonal therapy cancer brands generated sales of about $6.9 billion in the seven major pharmaceutical markets in 2008.

Research and analysis highlights

The antihormonals market was worth $6.9 billion in 2008 across the seven major pharmaceutical markets. Its growth within the next decade, at a marginal CAGR of 0.1%, will be predominantly limited by patent expiries of leading brands.
In 2008, Arimidex (anastrozole; AstraZeneca), Lupron (leuprolide; Takeda/Abbott) and Casodex (bicalutamide; AstraZeneca) were the three leading antihormonal brands in terms of sales. These will remain the top three brands through to 2018, even though Arimidex and Casodex will lose around 40% of their brand value due to generic competition.
In a mature market, the importance of product lifecycle management is high. AstraZeneca was the key player in the market in 2008, with an antihormonals portfolio valued at over $3.4 billion. With successful lifecycle management and a considerable investment in marketing activities, AstraZeneca has built a strong brand presence for its products.

Scope of this research

* In-depth analysis of the current and future antihormonal therapies market across the US, 5EU and Japan, plus a rest of world snapshot
* Antihormonal therapy sales forecasts for brands and generics from 2008 to 2018
* Assessment of the leading cancer brands and drug classes to identify key success factors within this sector
* Evaluation of the strategies of leading players in the antihormonals market

To purchase this Datamonitor report, Commercial Insight: Antihormonal Cancer Therapies - Stagnant sales indicative of a mature market, please contact:

reports-research.com
c/o dynamic technologies GmbH

info@reports-research.com
or
Tel ++49 (0)221 690 688 55
Fax ++49 (0)221 690 688 56

More information on this report:

Pages: 115
Tables: 44
Figures: 23
List price: $15,200
Published: 16 Jul 2009
Format: PDF, PowerPoint

Datamonitor: More market data and market reports:
http://www.reports-research.com/studien/datamonitor-m-29.html

markt-studie.de, founded in 2002 has emerged as a leading online portal for market surveys and market research in German speaking areas. Four years later the English language portal reports-research.com was introduced due to the extraordinary success of the portal. Again one year later estudio-mercado.es - the Spanish spoken portal - was founded. The objective of the three portals is to competently and efficiently support consultants and decision makers in management, sales and marketing in the search for worldwide market research. Prospective buyers can look into more than 60,000 market surveys from more than 200 international publishers, current market data for more than 6,000 branches worldwide, 10,000 company profiles as well as a free-of-charge research and recommendation service for individual market research.

reports-research.com
c/o dynamic technologies GmbH
Siegburger Str. 233
50679 Köln
Germany

Manuel Bravo Sanchez (CEO)

info@reports-research.com
or
Tel ++49 (0)221 690 688 55
Fax ++49 (0)221 690 688 56

This release was published on openPR.